Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Halozyme Therapeutics Inc. (HALO)

15.61   -0.31 (-1.95%) 05-17 16:00
Open: 15.73 Pre. Close: 15.92
High: 16.005 Low: 15.55
Volume: 509,246 Market Cap: 2262M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 16.037 - 16.116 16.116 - 16.18
Low: 15.332 - 15.439 15.439 - 15.526
Close: 15.461 - 15.622 15.622 - 15.753

Technical analysis

as of: 2019-05-17 4:29:01 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 19.49     One year: 20.36
Support: Support1: 15.49    Support2: 12.89
Resistance: Resistance1: 16.69    Resistance2: 17.43
Pivot: 16.29
Moving Average: MA(5): 15.74     MA(20): 16.27
MA(100): 16.19     MA(250): 16.77
MACD: MACD(12,26): -0.18     Signal(9): -0.08
Stochastic oscillator: %K(14,3): 14.60     %D(3): 14.66
RSI: RSI(14): 40.06
52-week: High: 19.56  Low: 13.24  Change(%): -16.1
Average Vol(K): 3-Month: 82679  10-Days: 78665

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
HALO has closed above bottom band by 16.6%. Bollinger Bands are 7.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 08 May 2019 03:12:51 Z
Halozyme Therapeutics Inc (HALO) Q1 2019 Earnings Call Transcript

Wed, 08 May 2019 00:14:25 Z
Halozyme Therapeutics (HALO) Matches Q1 Earnings Estimates

Tue, 30 Apr 2019 17:21:51 Z
Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?

Mon, 29 Apr 2019 15:08:34 Z
First Week of HALO December 20th Options Trading

Tue, 02 Apr 2019 21:00:34 Z
HALO Crosses Above Key Moving Average Level

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 145.51
Shares Float (M) 134.56
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.550
EPS Est. Current Year -0.130
EPS Est. Next Year -0.790
EPS Est. Next Quarter 0.270
Forward EPS -0.560
Book Value (p.s.) 9.140
PEG Ratio -0.66
Profit Margin -28.70
Operating Margin -23.97
Return on Assets (ttm) -11.1
Return on Equity (ttm) -19.5
Qtrly Rev. Growth 84.5
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -31.75
Levered Free Cash Flow (M) -16.21

Stock Valuations

P/E -28.38
P/E Growth Ratio -0.02
P/BV 1.71
P/S 1824104064.00
P/CF -71.54

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.